Since KIR expression is also found on different T-cell subtypes, variant expression could also be critical for disease development in cell types other than NK cells, and it will thus be a challenge for future analysis to identify effector and target cells with altered KIR/Bw4 interaction in BD. This evidence concerns the gene KIR3DL1 and Behcet disease.